Literature DB >> 16216384

The clinical significance of methicillin-resistant Staphylococcus aureus.

I M Gould1.   

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) is responsible for the largest outbreak of hospital-acquired infection (HAI) that the world has ever seen. It is not replacing methicillin-susceptible S. aureus (MSSA), but seems largely to be an additional burden of HAI with double the mortality of MSSA infections, at least in the bacteraemic form. It is often highly transmissible and carriage seems to lead to clinical infection much more frequently than with MSSA carriage. Additional screening for MRSA needs to be performed, not only to establish the size of the problem and to allow initiation of decolonization measures to prevent the onset of clinical disease, but also to allow implementation of infection control precautions that will be necessary to control the epidemic. MRSA is a huge clinical burden that is causing great public and political concern. Current treatments are suboptimal. Control measures are likely to be effective and cost saving if they have a broad enough base, and should be implemented without further delay.

Entities:  

Mesh:

Year:  2005        PMID: 16216384     DOI: 10.1016/j.jhin.2005.06.014

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  34 in total

1.  Recombinant ESAT-6-like proteins provoke protective immune responses against invasive Staphylococcus aureus disease in a murine model.

Authors:  Bao Zhong Zhang; Yan Hong Hua; Bin Yu; Candy Choi Yi Lau; Jian Piao Cai; Song Yue Zheng; Wing Cheong Yam; Richard Yi Tsun Kao; Kong Hung Sze; Bo Jian Zheng; Kwok Yung Yuen; Jian Dong Huang
Journal:  Infect Immun       Date:  2014-11-03       Impact factor: 3.441

2.  Antimicrobial activity of methanolic extracts of Sambucus ebulus and Urtica dioica against clinical isolates of methicillin resistant Staphylococcus aureus.

Authors:  Ali Salehzadeh; Leila Asadpour; Akram Sadat Naeemi; Elham Houshmand
Journal:  Afr J Tradit Complement Altern Med       Date:  2014-08-23

3.  MRSA colonisation (eradicating colonisation in people without active invasive infection).

Authors:  Suzanne F Bradley
Journal:  BMJ Clin Evid       Date:  2015-11-13

4.  Exposure of Staphylococcus aureus to Targocil Blocks Translocation of the Major Autolysin Atl across the Membrane, Resulting in a Significant Decrease in Autolysis.

Authors:  Kiran B Tiwari; Craig Gatto; Suzanne Walker; Brian J Wilkinson
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

Review 5.  Larval therapy from antiquity to the present day: mechanisms of action, clinical applications and future potential.

Authors:  Iain S Whitaker; Christopher Twine; Michael J Whitaker; Mathew Welck; Charles S Brown; Ahmed Shandall
Journal:  Postgrad Med J       Date:  2007-06       Impact factor: 2.401

Review 6.  MRSA colonisation (eradicating colonisation in people without active/invasive infection).

Authors:  Suzanne F Bradley
Journal:  BMJ Clin Evid       Date:  2011-01-17

7.  Analysis of MRSA-attributed costs of hospitalized patients in Germany.

Authors:  C Hübner; N-O Hübner; K Hopert; S Maletzki; S Flessa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-18       Impact factor: 3.267

8.  Chronological changes in microbial profiles in external and middle ear diseases: a 20-year study in Korea.

Authors:  Hantai Kim; Oak-Sung Choo; Jeong Hun Jang; Hun Yi Park; Yun-Hoon Choung
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-11-23       Impact factor: 2.503

9.  Antimicrobial resistance of Staphylococcus from otorrhea in chronic suppurative otitis media and comparison with results of all isolated Staphylococci.

Authors:  D C Park; S K Lee; C I Cha; S-O Lee; M S Lee; S G Yeo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-02-26       Impact factor: 3.267

10.  Inactivation of staphylococcal virulence factors using a light-activated antimicrobial agent.

Authors:  Sarah Tubby; Michael Wilson; Sean P Nair
Journal:  BMC Microbiol       Date:  2009-10-05       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.